Metabotropic glutamate receptors 5 blockade reverses spatial memory deficits in a mouse model of Parkinson's disease.
about
Pharmacological modulation of glutamate transmission in a rat model of L-DOPA-induced dyskinesia: effects on motor behavior and striatal nuclear signalingAlterations in mGluR5 expression and signaling in Lewy body disease and in transgenic models of alpha-synucleinopathy--implications for excitotoxicity.Cognitive dysfunction and depression in Parkinson's disease: what can be learned from rodent models?Effects of ketoconazole treatment on the pharmacokinetics of safinamide and its plasma metabolites in healthy adult subjects.Activation of type 5 metabotropic glutamate receptors attenuates deficits in cognitive flexibility induced by NMDA receptor blockade.Glutamate receptors as therapeutic targets for Parkinson's disease.Neurotransmission in Parkinson's disease: beyond dopamine.Metabotropic glutamate receptor subtype 5 antagonism in learning and memory.Cognitive impairment in nondemented Parkinson's disease.Targeting glutamate receptors to tackle the pathogenesis, clinical symptoms and levodopa-induced dyskinesia associated with Parkinson's disease.Therapeutic potential of targeting metabotropic glutamate receptors for Parkinson's disease.Therapeutic potential of targeting glutamate receptors in Parkinson's disease.Safinamide for the treatment of Parkinson's disease.Absolute Bioavailability and Effect of Food on the Disposition of Safinamide Immediate Release Tablets in Healthy Adult Subjects.Changes of brain gray matter structure in Parkinson's disease patients with dementiaThe effects of pergolide on memory and oxidative stress in a rat model of Parkinson's disease.Motor learning and metaplasticity in striatal neurons: relevance for Parkinson's disease.Negative versus positive allosteric modulation of metabotropic glutamate receptors (mGluR5): indices for potential pro-cognitive drug properties based on EEG network oscillations and sleep-wake organization in rats.Interaction between the mGlu receptors 5 antagonist, MPEP, and amphetamine on memory and motor functions in mice.Pressor response to oral tyramine during co-administration with safinamide in healthy volunteers.Hippocampal protein kinase D1 is necessary for DHPG-induced learning and memory impairments in rats.Targeting mGlu5 Metabotropic Glutamate Receptors in the Treatment of Cognitive Dysfunction in a Mouse Model of Phenylketonuria.
P2860
Q33428476-02D792DB-B2B6-4D77-9546-DAC77F5157B4Q33754643-071BCCC6-B4C7-4B48-9E2E-E637D2D29050Q34307633-BCCB5ABB-5C07-4714-B98A-FC575BDEC21BQ34308118-B16E95FF-BC43-4F9B-A75D-1C15C22EEFBCQ35984134-C8C0E3DE-2A0E-43F5-A6D1-52308F2957D6Q37585401-BAF1F9E4-D6DB-498F-992F-34EDC8CFF0D7Q37668684-CC8FD2B2-F5F3-42DE-AC3F-45D3F6372136Q37723772-87ED65B0-723F-429E-AE01-13FD6F66016FQ37968511-DC76FCBB-9709-4324-AAAB-1CB306DD9EE4Q38056852-2C81987C-9BED-4F8D-AE72-F21ECB0F8158Q38092819-6C9819A8-7A4A-441A-9ACF-6F99E2656D25Q38190016-D8DA8B73-6CC7-4EFC-9AF0-DBF3D3AFC9D1Q38197710-4BAE3D8A-4A1C-46BC-B0B6-B6521DB08060Q39816506-F83212BB-142F-495C-B917-DD323E8DB2ADQ42744489-45CF1B63-9549-41B5-AE02-F85B3DA6F6E3Q45903649-A0D49439-8BCB-4EE3-AA6C-53A29FBC041DQ47569238-BD638647-CE0B-47C0-8F4D-AC38FCE857A4Q48022620-0869B16A-800A-473D-93CC-2F3A2A49B981Q50773434-6373E0F5-F925-4D62-B290-9A9798CD8530Q51369362-03AD3A73-DE23-4BA0-A243-4C1EB0DEBC7EQ54118045-E92BD427-6C46-4CF7-AC45-C38CC6E9A157Q55352164-E11E383E-CB5F-4F6F-A26C-46520F553799
P2860
Metabotropic glutamate receptors 5 blockade reverses spatial memory deficits in a mouse model of Parkinson's disease.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Metabotropic glutamate recepto ...... model of Parkinson's disease.
@en
Metabotropic glutamate recepto ...... model of Parkinson's disease.
@nl
type
label
Metabotropic glutamate recepto ...... model of Parkinson's disease.
@en
Metabotropic glutamate recepto ...... model of Parkinson's disease.
@nl
prefLabel
Metabotropic glutamate recepto ...... model of Parkinson's disease.
@en
Metabotropic glutamate recepto ...... model of Parkinson's disease.
@nl
P2860
P50
P356
P1476
Metabotropic glutamate recepto ...... model of Parkinson's disease.
@en
P2860
P2888
P304
P356
10.1038/NPP.2008.129
P4011
5b25e324a8312e521f484b61d3a368eecac8de17
P407
P50
P577
2008-08-13T00:00:00Z